Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Kenneth Cusi MD, FACP, FACE

Kenneth Cusi MD, FACP, FACE

Professor of Medicine; Chief, Division of Endocrinology, Diabetes and Metabolism, University of Florida; Acting Chief, Division of Endocrinology, Diabetes and Metabolism, Malcolm Randall Veterans Administration Medical Center, Gainesville, Florida

Dr. Cusi is a Professor of Medicine and Chief of the Division of Endocrinology, Diabetes and Metabolism at The University of Florida at Gainesville (2011-present). He is also a faculty and researcher at the Endocrinology, Diabetes and Metabolism Division at the Veterans Administration Medical Center at Gainesville, FL.

Dr. Cusi has published numerous reviews, book chapters and original articles in a broad spectrum of peer-reviewed journals, such as the New England Journal of Medicine, Annals of Internal Medicine, Proceeding of the National Academy of Science, Journal of Clinical Investigation, Diabetes, Diabetes Care, J Clinical Endocrinology and Metabolism, American Journal of Physiology, Hepatology, Gastroenterology and others. He is an associate editor and reviewer for many journals in the fields of endocrinology, metabolism, diabetes and liver disease. He is a frequent invited lecturer to national and international meetings on the role of obesity and NAFLD in T2DM.  

He is also co-founder and vice-president of Children in Need (, a philanthropic organization aimed at improving the living conditions and education of children in Africa.


Financial Disclosures

Research studies: Janssen, Novartis, Novo Nordisk, Octeta.

Consultant: Deuterex, Janssen, Kowa, Lilly, Novartis, Novo Nordisk, Pfizer, Teva, Tobira, Zydus